N@N

Market Maker Surveillance Report. JBLU, ARNA, MSFT, ACTC, SD, SUTNY, Highest Net Sell Volume and Negative Price Friction For W

January 11, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3694 companies with "abnormal" market making, 3104 companies with positive Friction Factors and 2797 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Wednesday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Jetblue Airways Corp (NASDAQ:JBLU), ARENA PHARMACEUTICALS INC (NASDAQ:ARNA), MICROSOFT CORPORATION (NASDAQ:MSFT), ADVANCED CELL TECHNOLOGY INC (OTCBB:ACTC), SANDRIDGE ENERGY INC (NYSE:SD), (OTC:SUTNY). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     JBLU       $-0.250      -4.22%       8,770,960       38.19%       14,203,747      61.84%       -5,432,787      -217,311
     ARNA       $-0.090      -5.11%       2,833,154       35.62%       5,120,826       64.38%       -2,287,672      -254,186
     MSFT       $-0.050      -0.18%       29,868,744      44.56%       36,595,738      54.60%       -6,726,994      -1,345,399
     ACTC       $-0.026      -15.94%      14,870,132      44.57%       18,481,930      55.40%       -3,611,798      -1,416,391
     SD         $-0.260      -2.98%       3,862,163       25.19%       6,743,473       43.98%       -2,881,310      -110,820
     SUTNY      $-0.040      -1.34%       304,466         9.49%        2,891,783       90.12%       -2,587,317      -646,829

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have low price friction combined with more selling than buying (negative Net Volume) in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows JBLU down $-0.25000 with a Friction Factor of -217,311 and a Net Volume of -5,432,787. That means that it takes 217,311 more shares of selling than buying to drop JBLU by one penny. On Monday the Market Makers allowed the stock to move down on heavier selling than buying (low negative friction).

Jetblue Airways Corp (NASDAQ:JBLU) - JetBlue Airways Corporation provides passenger air transportation services in the United States. As of December 31, 2010, it operated 650 daily flights to 63 destinations in 21 states, Puerto Rico, and Mexico; and 10 countries in the Caribbean and Latin America through a fleet of 115 Airbus A320 aircrafts and 45 EMBRAER 190 aircrafts. The company, through its subsidiary, LiveTV, LLC, provides in-flight entertainment, voice communication, and data connectivity systems and services for commercial and general aviation aircraft, including live in-seat satellite television, digital satellite radio, wireless aircraft data link service, and cabin surveillance systems. JetBlue Airways Corporation was founded in 1998 and is based in Forest Hills, New York.

ARENA PHARMACEUTICALS INC (NASDAQ:ARNA) - Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company also discovers small molecule drug candidates that target G protein-coupled receptors (GPCRs). Its clinical development programs include lorcaserin that has completed Phase III clinical trials for the treatment of weight management; APD791, an anti-thrombotic drug candidate, which completed Phase Ia and Phase Ib clinical trials; APD597 that is in Phase I clinical trials for the treatment of type II diabetes; APD916, which has completed preclinical development for the treatment of narcolepsy and cataplexy; and APD811, a preclinical drug candidate for the treatment of pulmonary arterial hypertension. The companys drug candidates use GPCR-focused drug discovery and development approach, as well as technologies, including Constitutively Activated Receptor Technology and Melanophore Technology. It has collaboration agreements with Ortho-McNeil-Janssen Pharmaceuticals, Inc. to further develop compounds for the potential treatment of type II diabetes and other disorders; and Merck & Co., Inc. to develop therapeutics for atherosclerosis and other disorders. Arena Pharmaceuticals also has a strategic cooperation agreement with Siegfried Ltd to manufacture lorcaserin. The company was founded in 1997 and is based in San Diego, California.

MICROSOFT CORPORATION (NASDAQ:MSFT) - Microsoft Corporation develops, manufactures, licenses, and supports a range of software products and services for various computing devices worldwide. The companys Windows & Windows Live Division segment offers Windows operating system, Windows Live, and Internet Explorer. It offers Windows operating system, which include Windows 7, Windows Vista, and Windows XP Home, as well as Windows Live suite of applications and Web services. Microsofts Server and Tools segment provides Windows Server operating systems, Windows Azure, Microsoft SQL Server, SQL Azure, Visual Studio, Silverlight, System Center products, Biz Talk server, Microsoft consulting services, and product support services. This segment also provides enterprise consulting and product support services; and training and certification to developers and information technology professionals, as well as builds standalone and software development lifecycle tools for software architects, developers, testers, and project managers. The companys Online Services Division segment offers online information products, such as Bing, MSN portals, and channels; and an online advertising platform for publishers and advertisers. Microsofts Microsoft Business Division segment offers Microsoft Office, Microsoft SharePoint, and Microsoft Dynamics ERP and CRM, as well as Microsoft Office Web Apps. The companys Entertainment and Devices Division segment develops, produces, and markets the Xbox 360 platform; PC software games; online games and services; Mediaroom, an Internet protocol television software; Windows Phone and Windows Embedded device platforms; the Zune digital music and entertainment platform; and application software for Apples Macintosh computers, Microsoft PC hardware products, and other devices. This segment also involves in retail and marketing of packaged versions of the Microsoft Office system and the Windows operating systems. Microsoft was founded in 1975 and is headquartered in Redmond, Washington.

ADVANCED CELL TECHNOLOGY INC (OTCBB:ACTC) - Advanced Cell Technology, Inc., a biotechnology company, focuses on the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. It primarily focuses on cellular reprogramming, reduced complexity program, and stem cell differentiation research programs. The companys cellular reprogramming involves in the development of therapies based on the use of genetically identical pluripotent stem cells generated by its cellular reprogramming technologies. Advanced Cell Technology, Inc. is also generating stable cell lines with particular focus on blood lineage and vascular epithelial cell lines from hemangioblast cells. In addition, it is developing an autologous myoblast transplantation therapy to restore cardiac function in patients with advanced heart disease. The companys stem cell-based therapy would provide treatment for a range of acute and chronic degenerative diseases. Further, it develops adult stem cell-based products that are specifically targeted at therapies for heart and other cardiovascular diseases. The company is headquartered in Worcester, Massachusetts.

SANDRIDGE ENERGY INC (NYSE:SD) - SandRidge Energy, Inc., together with its subsidiaries, operates as an independent natural gas and oil company in the United States. The company engages in the exploration, development, and production of oil and gas properties. Its Exploration and Production segment explores for, develops, and produces natural gas and oil reserves in the West Texas Overthrus (WTO) and the Permian Basin. The companys Drilling and Oil Field Services segment drills wells for other oil and natural gas companies, primarily in the west Texas region. This segments oil field services include providing drilling rigs, pulling units, mud logging, trucking, rental tools, location and road construction, and roustabout services to third-parties. Its Midstream Gas Services segment provides gathering, compression, processing, and treating services of natural gas in west Texas. The company also captures and transports CO2 to the Permian Basin for use in tertiary oil recovery operations, as well as operates interests in the Mid-Continent, the Cotton Valley Trend in east Texas, the Gulf Coast, and the Gulf of Mexico. As of December 31, 2009, it had estimated proved reserves of 1,312.2 Bcfe, of which 52% were natural gas. The company also had 3,373 gross producing wells, as well as had oil interests in 1,720,909 gross leased acres. In addition, it had 8 rigs drilling in the WTO, 4 rigs drilling in the Permian Basin, 2 rigs drilling in East Texas, and 1 rig drilling in the Mid-Continent. The company, formerly known as Riata Energy, Inc., was founded in 1984 and is headquartered in Oklahoma City, Oklahoma.

(OTC:SUTNY) -

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net